Literature DB >> 25114841

Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management.

Mei R Fu1.   

Abstract

The global burden of breast cancer continues to increase largely because of the aging and growth of the world population. More than 1.38 million women worldwide were estimated to be diagnosed with breast cancer in 2008, accounting for 23% of all diagnosed cancers in women. Given that the 5-year survival rate for breast cancer is now 90%, experiencing breast cancer is ultimately about quality of life. Women treated for breast cancer are facing a life-time risk of developing lymphedema, a chronic condition that occurs in up to 40% of this population and negatively affects breast cancer survivors' quality of life. This review offers an insightful understanding of the condition by providing clinically relevant and evidence based knowledge regarding lymphedema symptoms, diagnosis, risk reduction, and management with the intent to inform health care professionals so that they might be better equipped to care for patients.

Entities:  

Keywords:  Breast cancer; Diagnosis; Lymphedema; Management; Risk reduction; Symptoms

Year:  2014        PMID: 25114841      PMCID: PMC4127597          DOI: 10.5306/wjco.v5.i3.241

Source DB:  PubMed          Journal:  World J Clin Oncol        ISSN: 2218-4333


  38 in total

1.  Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study.

Authors:  Marilyn L Kwan; Jeanne Darbinian; Kathryn H Schmitz; Rebecca Citron; Paula Partee; Susan E Kutner; Lawrence H Kushi
Journal:  Arch Surg       Date:  2010-11

2.  A comparison of four diagnostic criteria for lymphedema in a post-breast cancer population.

Authors:  Jane M Armer; Bob R Stewart
Journal:  Lymphat Res Biol       Date:  2005       Impact factor: 2.589

3.  Minimal limb volume change has a significant impact on breast cancer survivors.

Authors:  J N Cormier; Y Xing; I Zaniletti; R L Askew; B R Stewart; J M Armer
Journal:  Lymphology       Date:  2009-12       Impact factor: 1.286

Review 4.  The surgical treatment of lymphedema: a systematic review of the contemporary literature (2004-2010).

Authors:  Janice N Cormier; Loren Rourke; Melissa Crosby; David Chang; Jane Armer
Journal:  Ann Surg Oncol       Date:  2011-08-24       Impact factor: 5.344

5.  The effect of providing information about lymphedema on the cognitive and symptom outcomes of breast cancer survivors.

Authors:  Mei R Fu; Constance M Chen; Judith Haber; Amber A Guth; Deborah Axelrod
Journal:  Ann Surg Oncol       Date:  2010-02-06       Impact factor: 5.344

6.  Complete reduction of lymphoedema of the arm by liposuction after breast cancer.

Authors:  H Brorson; H Svensson
Journal:  Scand J Plast Reconstr Surg Hand Surg       Date:  1997-06

Review 7.  Preventative measures for lymphedema: separating fact from fiction.

Authors:  Yeliz Cemal; Andrea Pusic; Babak J Mehrara
Journal:  J Am Coll Surg       Date:  2011-07-28       Impact factor: 6.113

Review 8.  Psychosocial impact of living with cancer-related lymphedema.

Authors:  Mei R Fu; Yang Kang
Journal:  Semin Oncol Nurs       Date:  2013-02       Impact factor: 2.315

9.  Symptom burden and infection occurrence among individuals with extremity lymphedema.

Authors:  S H Ridner; J Deng; M R Fu; E Radina; S R J Thiadens; J Weiss; M S Dietrich; J N Cormier; C M Tuppo; J M Armer
Journal:  Lymphology       Date:  2012-09       Impact factor: 1.286

Review 10.  Liposuction in arm lymphedema treatment.

Authors:  H Brorson
Journal:  Scand J Surg       Date:  2003       Impact factor: 2.360

View more
  37 in total

Review 1.  Age as a risk factor for breast cancer-related lymphedema: a systematic review.

Authors:  Gunel Guliyeva; Maria T Huayllani; Daniel Boczar; Francisco R Avila; Xiaona Lu; Antonio Jorge Forte
Journal:  J Cancer Surviv       Date:  2021-01-24       Impact factor: 4.442

2.  A Comparison of the Quality of Life in Patients With Primary and Secondary Lower Limb Lymphedema: A Mixed-Methods Study.

Authors:  Deonni P Stolldorf; Mary S Dietrich; Sheila H Ridner
Journal:  West J Nurs Res       Date:  2016-05-05       Impact factor: 1.967

Review 3.  Use of technology to facilitate a prospective surveillance program for breast cancer-related lymphedema at the Massachusetts General Hospital.

Authors:  Lauren M Havens; Cheryl L Brunelle; Tessa C Gillespie; Madison Bernstein; Loryn K Bucci; Yara W Kassamani; Alphonse G Taghian
Journal:  Mhealth       Date:  2021-01-20

4.  Knowledge of Primary Care Physicians About Breast-Cancer-Related Lymphedema: Turkish Perspective.

Authors:  Gul Mete Civelek; Cenk Aypak; Ozlem Turedi
Journal:  J Cancer Educ       Date:  2016-12       Impact factor: 2.037

Review 5.  Treating Persistent Pain After Breast Cancer Surgery.

Authors:  James S Khan; Karim S Ladha; Faraj Abdallah; Hance Clarke
Journal:  Drugs       Date:  2020-01       Impact factor: 9.546

6.  Effect of pneumatic compression therapy on lymph movement in lymphedema-affected extremities, as assessed by near-infrared fluorescence lymphatic imaging.

Authors:  Melissa B Aldrich; Deborah Gross; John Rodney Morrow; Caroline E Fife; John C Rasmussen
Journal:  J Innov Opt Health Sci       Date:  2016-09-28

Review 7.  Lymphedema: Conventional to Cutting Edge Treatment.

Authors:  Duane Wang; Daniel Lyons; Roman Skoracki
Journal:  Semin Intervent Radiol       Date:  2020-07-31       Impact factor: 1.513

8.  Effects of complex decongestive therapy on quality of life, depression, neuropathic pain, and fatigue in women with breast cancer-related lymphedema.

Authors:  Hilal Yesil; Sibel Eyigör; İsmail Caramat; Rıdvan Işık
Journal:  Turk J Phys Med Rehabil       Date:  2017-11-13

9.  Is kinesiophobia associated with lymphedema, upper extremity function, and psychological morbidity in breast cancer survivors?

Authors:  Aslı Gencay Can; Serdar Süleyman Can; Emel Ekşioğlu; Fatma Aytül Çakcı
Journal:  Turk J Phys Med Rehabil       Date:  2018-08-12

10.  Five-Year Breast Surgeon Experience in LYMPHA at Time of ALND for Treatment of Clinical T1-4N1-3M0 Breast Cancer.

Authors:  Kelly M Herremans; Morgan P Cribbin; Andrea N Riner; Dan W Neal; Tracy L Hollen; Pamela Clevenger; Derly Munoz; Shannon Blewett; Fantine Giap; Paul G Okunieff; Nancy P Mendenhall; Julie A Bradley; William M Mendenhall; Raymond B Mailhot-Vega; Eric Brooks; Karen C Daily; Coy D Heldermon; Julia K Marshall; Mariam W Hanna; Mark M Leyngold; Sarah S Virk; Christiana M Shaw; Lisa R Spiguel
Journal:  Ann Surg Oncol       Date:  2021-08-07       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.